Changchun Bcht Biotechnology Co.

This is an early-stage study to test the safety and immune response of a new mRNA vaccine designed to protect against genital herpes (HSV-2). It will enroll 144 healthy adults, testing different vaccine doses in people who have never had the virus and those who have. The main goa…

This is an early-stage safety study for a new freeze-dried version of a rabies vaccine. It will enroll 80 healthy volunteers aged 10-60 to test how safe the vaccine is when given on different schedules. The main goal is to monitor for any side effects in the 30 days after the fin…